The world of biotech stocks is exciting and volatile. A company can grow 1,000% overnight or lose 90% of its value instantly as a result of a failed study and everything in between. The financial opportunity, is immense if you make timely and well-informed investment decisions. To do this you will need to know how to navigate online resources to conduct due diligence on biotech companies. This is what you will learn to do in this course.
Roughly 50% of drugs that enter clinical development fail to ever get FDA approved. Many of those drugs that do reach the commercialization-stage fail to generate meaningful revenue. These types of companies are usually heavily diluted and or indebted because of the continual need to issue new stock and or take out loans to fund operations.
Then there are, the select few companies that bring to market products that go on to achieve hundreds of millions or even billions of dollars in annual peak sales revenue ($1B+/year revenue = Blockbuster). These types of companies are often referred to as “Big Pharma (BP)”.
The lure of investing in small-cap biotech stocks is that you do not need to park your money for years to see 2-10X returns. There are many catalysts throughout the lifetime of every biotech company enabling you to make 20-100%+ gains in a matter of months; sometimes in weeks or days.
However, if not done correctly, you can just as quickly lose money. For this reason, you need to be well educated on the ins and outs of investing in biotech stocks which are covered in this course.
In Chapter 1, we will introduce you to the biopharma industry, highlight important vocabulary, phrases, and major areas for drug development.
This quiz covers content from chapter 1
In Chapter 2, we will cover how to analyze and grade biopharma company's and their drug candidates. Additionally, we will show you how to swiftly find and analyze pertinent data/statistics.
This quiz covers material from chapter 2
In Chapter 3, we will overview the major regulatory bodies around the world, and focus on the regulatory processes involved with drug approval in the United States.